Works matching DE "EPIRUBICIN"

Results: 513

ESHAP versus IEV Chemotherapy for Relapsed or Refractory Hodgkin's and Non- Hodgkin's Lymphoma.

Published in:

International Journal of Hematology-Oncology & Stem Cell Research, 2025, v. 19, n. 2, p. 151

By:

Dehghani, Mehdi;
Vojdani, Reza;
Khalafi-Nezhad, Abolfazl;
Ravanbod, Mohammad Reza;
Ramzi, Mani;
Dehdashti, Shima;
Namdari, Nasrin

Publication type:

Article

F-α-DDB-derivative, a novel synthetic of bifendate, plus epirubicin improves antitumor efficacy against triple negative breast cancer without additional cardiotoxicity.

Published in:

Discover Oncology, 2025, v. 16, n. 1, p. 1, doi. 10.1007/s12672-025-02545-9

By:

Huang, Hai-yi;
Lin, Lisa Zong Yong;
Lu, Xin-yi;
Jiang, Ying

Publication type:

Article

Radiofrequency thermal ablation (RFA) after transarterial chemoembolization (TACE) as a combined therapy for unresectable non-early hepatocellular carcinoma (HCC).

Published in:

2006

By:

Veltri, Andrea;
Moretto, Paolo;
Doriguzzi, Andrea;
Pagano, Eva;
Carrara, Giovanna;
Gandini, Giovanni

Publication type:

journal article

Accuracy of tumor size measurement in breast cancer using MRI is influenced by histological regression induced by neoadjuvant chemotherapy.

Published in:

2003

By:

Wasser, K.;
Sinn, H. P.;
Fink, C.;
Klein, S. K.;
Junkermann, H.;
Lüdemann, H. P.;
Zuna, I.;
Delorme, S.;
Lüdemann, H P

Publication type:

journal article

A randomized phase II trial of two different 4-drug combinations in advanced pancreatic adenocarcinoma: cisplatin, capecitabine, gemcitabine plus either epirubicin or docetaxel (PEXG or PDXG regimen).

Published in:

Cancer Chemotherapy & Pharmacology, 2012, v. 69, n. 1, p. 115, doi. 10.1007/s00280-011-1680-2

By:

Reni, Michele;
Cereda, Stefano;
Rognone, Alessia;
Belli, Carmen;
Ghidini, Michele;
Longoni, Simonetta;
Fugazza, Clara;
Rezzonico, Sara;
Passoni, Paolo;
Slim, Najla;
Balzano, Giampaolo;
Nicoletti, Roberto;
Cappio, Stefano;
Doglioni, Claudio;
Villa, Eugenio

Publication type:

Article

Chemotherapy for endometrial carcinoma (GOGO-EM1 study): TEC (paclitaxel, epirubicin, and carboplatin) is an effective remission-induction and adjuvant therapy.

Published in:

Cancer Chemotherapy & Pharmacology, 2011, v. 68, n. 6, p. 1603, doi. 10.1007/s00280-011-1638-4

By:

Egawa-Takata, Tomomi;
Ueda, Yutaka;
Kuragaki, Chie;
Miyake, Takahito;
Miyatake, Takashi;
Fujita, Masami;
Yoshino, Kiyoshi;
Nakashima, Ryuichi;
Okazawa, Mika;
Tsutsui, Tateki;
Morishige, Ken-Ichirou;
Kimura, Tadashi;
Yamasaki, Masato;
Nishizaki, Takamichi;
Nagamatsu, Masaaki;
Ito, Kimihiko;
Asada, Masahiro;
Ogita, Kazuhide;
Wakimoto, Akinori;
Yamamoto, Toshiya

Publication type:

Article

Spectrophotometric investigation of the chemical compatibility of the anticancer drugs irinotecan-HCl and epirubicin-HCl in the same infusion solution.

Published in:

2005

By:

Ozdemir, Filiz Arioz;
Anilanmert, Beril;
Pekin, Mursit

Publication type:

journal article

Cisplatin and escalating doses of paclitaxel and epirubicin in advanced ovarian cancer. A phase I study.

Published in:

2001

By:

Nardi, Mario;
de Marco, Salvatore;
Fabi, Alessandra;
Aloe, Alessandra;
Magnani, Elena;
Pacetti, Umberto;
Carlini, Paolo;
Ruggeri, Enzo Maria;
Cognetti, Francesco;
Nardi, M;
De Marco, S;
Fabi, A;
Aloe, A;
Magnani, E;
Pacetti, U;
Carlini, P;
Ruggeri, E M;
Cognetti, F

Publication type:

journal article

Mono- and Combined Therapy of Metastasizing Breast Carcinoma 4T1 with Zoledronic Acid and Doxorubicin.

Published in:

Bulletin of Experimental Biology & Medicine, 2016, v. 161, n. 4, p. 580, doi. 10.1007/s10517-016-3464-5

By:

Baklaushev, V.;
Grinenko, N.;
Yusubalieva, G.;
Gubskii, I.;
Burenkov, M.;
Rabinovich, E.;
Ivanova, N.;
Chekhonin, V.

Publication type:

Article

Quantitative Evaluation of Primordial Follicles in Rat Ovaries during the Early and Delayed Terms after Different Cytostatic Exposures.

Published in:

Bulletin of Experimental Biology & Medicine, 2016, v. 161, n. 1, p. 61, doi. 10.1007/s10517-016-3345-y

By:

Borovskaya, T.;
Dygai, A.;
Fomina, T.;
Vychuzhanina, A.

Publication type:

Article

The use of water-soluble mucoadhesive gels for the intravesical delivery of epirubicin to the bladder for the treatment of non-muscle-invasive bladder cancer.

Published in:

Journal of Pharmacy & Pharmacology, 2015, v. 67, n. 10, p. 1355, doi. 10.1111/jphp.12441

By:

Chatta, Dani;
Cottrell, Lewis;
Burnett, Bruce;
Laverty, Garry;
McConville, Christopher

Publication type:

Article

Effect of low-protein diet on anthracycline pharmacokinetics and cardiotoxicity.

Published in:

Journal of Pharmacy & Pharmacology, 2012, v. 64, n. 3, p. 344, doi. 10.1111/j.2042-7158.2011.01413.x

By:

El-Demerdash, Ebtehal;
Ali, Azza A.;
El-Taher, Dalia E.M.;
Hamada, Farid M.A.

Publication type:

Article

Effects of HepaSphere microsphere encapsule epirubicin with a new loading method transarterial chemoembolization: in vitro and in vivo experiments.

Published in:

Discover Oncology, 2023, v. 14, n. 1, p. 1, doi. 10.1007/s12672-023-00831-y

By:

Zhang, Wen;
Du, Nan;
Wang, Liangwen;
Yu, Jiaze;
Yang, Minjie;
Zhang, Wei;
Qu, Xvdong;
Luo, Jianjun;
Yan, Zhiping

Publication type:

Article

Addition of epirubicin to conventional chemotherapy in patients with advanced ovarian cancer: sequential therapy - a retrospective evaluation.

Published in:

Turkish Journal of Medical Sciences, 2014, v. 44, n. 2, p. 212, doi. 10.3906/sag-1203-69

By:

ÖZGÜL, Nejat;
KÖSE, Mehmet Faruk;
KESKIN, Hüseyin Levent;
TURAN, Ahmet Taner;
KARALÖK, Mustafa Alper;
ÜREYEN, Isin;
BORAN, Nurettin;
TULUNAY, Hakki Gökhan

Publication type:

Article

Anthracycline-induced cardiomyopathy in a dog treated with epirubicin.

Published in:

2015

By:

Ye-Rin Lee;
Min-Hee Kang;
Hee-Myung Park

Publication type:

Case Study

A case of metastatic eccrine porocarcinoma without actionable mutations treated with carboplatin and epirubicin chemotherapy.

Published in:

Australasian Journal of Dermatology, 2021, v. 62, n. 3, p. e448, doi. 10.1111/ajd.13584

By:

Tahara, Jumpei;
Ishida, Yoshihiro;
Otsuka, Atsushi;
Komatsu‐Fujii, Takayoshi;
Yamamura, Kentaro;
Kaku, Yo;
Endo, Yuichiro;
Nomura, Takashi;
Irie, Hiroyuki;
Kabashima, Kenji

Publication type:

Article

SYNTHESIS AND CHARACTERIZATION OF DRUG - MINERAL CLAY HYBRID MATERIALS FOR BIOMEDICAL APPLICATIONS AS DRUG DELIVERY SYSTEMS - PART I.

Published in:

Romanian Journal of Materials / Revista Romana de Materiale, 2016, v. 46, n. 2, p. 133

By:

GEANALIU-NICOLAE, RUXANDRA-ELENA;
PÎRVAN, ADRIAN-ALEXANDRU;
ANDRONESCU, ECATERINA;
TRUȘCĂ, ROXANA

Publication type:

Article

In silico design of novel bioactive molecules to treat breast cancer with chlorogenic acid derivatives: a computational and SAR approach.

Published in:

Frontiers in Pharmacology, 2023, p. 1, doi. 10.3389/fphar.2023.1266833

By:

Sehrawat, Renu;
Rathee, Priyanka;
Rathee, Pooja;
Khatkar, Sarita;
Akkol, Esra Küpeli;
Khatkar, Anurag;
Sobarzo-Sánchez, Eduardo

Publication type:

Article

Epirubicin and gait apraxia: a real-world data analysis of the FDA Adverse Event Reporting System database.

Published in:

Frontiers in Pharmacology, 2023, p. 01, doi. 10.3389/fphar.2023.1249845

By:

Wei Wang;
Xin Guan;
Shuang Wang;
Lipeng Shi;
Yanfei Zhu;
Pengbo Hua;
Qiang Guo;
Jingqi Wang

Publication type:

Article

Evidence-based pharmacoeconomic evaluation of palbociclib in combination with letrozole versus docetaxel in combination with epirubicin in the first-line treatment of advanced breast cancer with epirubicin.

Published in:

Journal of Chinese Pharmaceutical Sciences, 2023, v. 32, n. 3, p. 214, doi. 10.5246/jcps.2023.03.019

By:

Ciyan Peng;
Jing Chen;
Sini Li;
Jianhe Li;
Liubao Peng

Publication type:

Article

Neoadjuvant–adjuvant pertuzumab in HER2-positive early breast cancer: final analysis of the randomized phase III PEONY trial.

Published in:

Nature Communications, 2024, v. 15, n. 1, p. 1, doi. 10.1038/s41467-024-45591-7

By:

Huang, Liang;
Pang, Da;
Yang, Hongjian;
Li, Wei;
Wang, Shusen;
Cui, Shude;
Liao, Ning;
Wang, Yongsheng;
Wang, Chuan;
Chang, Yuan-Ching;
Wang, Hwei-Chung;
Kang, Seok Yun;
Seo, Jae Hong;
Shen, Kunwei;
Laohawiriyakamol, Suphawat;
Jiang, Zefei;
Wang, Haiyan;
Lamour, François;
Song, Grace;
Curran, Michelle

Publication type:

Article

Neoadjuvant camrelizumab plus nab-paclitaxel and epirubicin in early triple-negative breast cancer: a single-arm phase II trial.

Published in:

Nature Communications, 2023, v. 14, n. 1, p. 1, doi. 10.1038/s41467-023-42479-w

By:

Wang, Chengzheng;
Liu, Zhenzhen;
Chen, Xiuchun;
Qiao, Jianghua;
Lu, Zhenduo;
Li, Lianfang;
Sun, Xianfu;
Zhang, Chongjian;
Yue, Xiayu;
Xia, Qingxin;
Zhang, He;
Yan, Min

Publication type:

Article

Dermal delivery of doxorubicin-loaded solid lipid nanoparticles for the treatment of skin cancer.

Published in:

Journal of Microencapsulation, 2016, v. 33, n. 4, p. 372, doi. 10.1080/02652048.2016.1200150

By:

Tupal, Ailar;
Sabzichi, Mehdi;
Ramezani, Fatemeh;
Kouhsoltani, Maryam;
Hamishehkar, Hamed

Publication type:

Article

Doxorubicin-loaded galactose-conjugated poly( d,l -lactide-co-glycolide) nanoparticles as hepatocyte-targeting drug carrier.

Published in:

Journal of Microencapsulation, 2016, v. 33, n. 4, p. 315, doi. 10.1080/02652048.2016.1185474

By:

Margarida Cardoso, M.;
Peça, Inês N.;
Raposo, Cláudia D.;
Petrova, Krasimira T.;
Teresa Barros, M.;
Gardner, Rui;
Bicho, A.

Publication type:

Article

Construction and application of biotin-poloxamer conjugate micelles for chemotherapeutics.

Published in:

Journal of Microencapsulation, 2013, v. 30, n. 6, p. 538, doi. 10.3109/02652048.2012.758182

By:

Lin, Guang-Yong;
Lv, Hai-Feng;
Lu, Cui-Tao;
Chen, Li-Juan;
Lin, Min;
Zhang, Ming;
Zhao, Ying-Zheng;
Su, Zheng-Xing;
Shen, Xiao-Tong;
Jiang, Xi;
Jin, Rong-Rong;
Li, Xin

Publication type:

Article

Ocular surface and tear film abnormalities in women under adjuvant chemotherapy for breast cancer with the 5–Fluorouracil, Epirubicin and Cyclophosphamide (FEC) regimen.

Published in:

Hippokratia, 2013, v. 17, n. 2, p. 120

By:

Karamitsos, A.;
Kokkas, V.;
Goulas, A.;
Paraskevopoulos, P.;
Gougoulias, K.;
Karampatakis, V.;
Boboridis, K.

Publication type:

Article

Systemic Treatment in Soft Tissue Sarcomas: Are We Making a Difference?

Published in:

Cancers, 2025, v. 17, n. 5, p. 889, doi. 10.3390/cancers17050889

By:

Paudel, Amrit;
Chattopadhyay, Priya;
Rose, Brandon;
Watson, Aleksandra;
D'Amato, Gina;
Trent, Jonathan;
Bialick, Steven;
Jonczak, Emily

Publication type:

Article

Cancer Therapy-Induced Cardiotoxicity: Results of the Analysis of the UK DEFINE Database.

Published in:

Cancers, 2025, v. 17, n. 2, p. 311, doi. 10.3390/cancers17020311

By:

Chan, Stefanie Ho Yi;
Fitzpatrick, Raymond W.;
Layton, Deborah;
Webley, Sherael;
Salek, Sam

Publication type:

Article

Receptor for Hyaluronan Mediated Motility (RHAMM)/Hyaluronan Axis in Breast Cancer Chemoresistance.

Published in:

Cancers, 2024, v. 16, n. 21, p. 3600, doi. 10.3390/cancers16213600

By:

Fujisawa, Shiori;
Takagi, Kiyoshi;
Yamaguchi-Tanaka, Mio;
Sato, Ai;
Miki, Yasuhiro;
Miyashita, Minoru;
Tada, Hiroshi;
Ishida, Takanori;
Suzuki, Takashi

Publication type:

Article

Hyperthermic Intravesical Chemotherapy (HIVEC) Using Epirubicin in an Optimized Setting in Patients with NMIBC Recurrence after Failed BCG Therapy.

Published in:

Cancers, 2024, v. 16, n. 7, p. 1398, doi. 10.3390/cancers16071398

By:

Blanc, Julien;
Ruggiero, Jonathan;
Lucca, Ilaria;
Arnold, Nicolas;
Kiss, Bernhard;
Roth, Beat

Publication type:

Article

Adjuvant Docetaxel in Node-Negative Breast Cancer Patients: A Randomized Trial of AGO-Breast Study Group, German Breast Group, and EORTC-Pathobiology Group.

Published in:

Cancers, 2023, v. 15, n. 5, p. 1580, doi. 10.3390/cancers15051580

By:

Thomssen, Christoph;
Vetter, Martina;
Kantelhardt, Eva J.;
Meisner, Christoph;
Schmidt, Marcus;
Martin, Pierre M.;
Clatot, Florian;
Augustin, Doris;
Hanf, Volker;
Paepke, Daniela;
Meinerz, Wolfgang;
Hoffmann, Gerald;
Wiest, Wolfgang;
Sweep, Fred C. G. J.;
Schmitt, Manfred;
Jänicke, Fritz;
Loibl, Sibylle;
Minckwitz, Gunter von;
Harbeck, Nadia

Publication type:

Article

The Comparative Safety of Epirubicin and Cyclophosphamide versus Docetaxel and Cyclophosphamide in Lymph Node-Negative, HR-Positive, HER2-Negative Breast Cancer (ELEGANT): A Randomized Trial.

Published in:

Cancers, 2022, v. 14, n. 13, p. N.PAG, doi. 10.3390/cancers14133221

By:

Liu, Deyue;
Wu, Jiayi;
Lin, Caijin;
Ding, Shuning;
Lu, Shuangshuang;
Fang, Yan;
Huang, Jiahui;
Hong, Jin;
Gao, Weiqi;
Zhu, Siji;
Chen, Xiaosong;
Huang, Ou;
He, Jianrong;
Chen, Weiguo;
Li, Yafen;
Shen, Kunwei;
Zhu, Li

Publication type:

Article

Dynamics of Serum Thymidine Kinase 1 at the First Cycle of Neoadjuvant Chemotherapy Predicts Outcome of Disease in Estrogen-Receptor-Positive Breast Cancer.

Published in:

Cancers, 2021, v. 13, n. 21, p. 5442, doi. 10.3390/cancers13215442

By:

Tribukait, Bernhard

Publication type:

Article

Hypnosis Sedation Reduces the Duration of Different Side Effects of Cancer Treatments in Breast Cancer Patients Receiving Neoadjuvant Chemotherapy.

Published in:

Cancers, 2021, v. 13, n. 16, p. 4147, doi. 10.3390/cancers13164147

By:

Berliere, Martine;
Piette, Nathan;
Bernard, Marion;
Lacroix, Camille;
Gerday, Amandine;
Samartzi, Vasiliki;
Coyette, Maude;
Roelants, Fabienne;
Docquier, Marie-Agnes;
Touil, Nassim;
Watremez, Christine;
Piette, Philippe;
Duhoux, Fran×ois P.

Publication type:

Article

The New Serum-Free OptiPASS ® Medium in Cold and Oxygen-Free Conditions: An Innovative Conservation Method for the Preservation of MDA-MB-231 Triple Negative Breast Cancer Spheroids.

Published in:

Cancers, 2021, v. 13, n. 8, p. 1945, doi. 10.3390/cancers13081945

By:

Goisnard, Antoine;
Dubois, Clémence;
Daumar, Pierre;
Aubel, Corinne;
Depresle, Marie;
Gauthier, Jean;
Vidalinc, Bernard;
Penault-Llorca, Frédérique;
Mounetou, Emmanuelle;
Bamdad, Mahchid;
Puig Miquel, Teresa;
Ciurana Gay, Joaquim;
Munshi, Anupama

Publication type:

Article

A Splice Variant of NCOR2, BQ323636.1, Confers Chemoresistance in Breast Cancer by Altering the Activity of NRF2.

Published in:

Cancers, 2020, v. 12, n. 3, p. 533, doi. 10.3390/cancers12030533

By:

Leung, Man-Hong;
Tsoi, Ho;
Gong, Chun;
Man, Ellen PS;
Zona, Stefania;
Yao, Shang;
Lam, Eric W.-F.;
Khoo, Ui-Soon

Publication type:

Article

Clinical Relevance of Collagen Protein Degradation Markers C3M and C4M in the Serum of Breast Cancer Patients Treated with Neoadjuvant Therapy in the GeparQuinto Trial.

Published in:

Cancers, 2019, v. 11, n. 8, p. 1186, doi. 10.3390/cancers11081186

By:

Banys-Paluchowski, Malgorzata;
Loibl, Sibylle;
Witzel, Isabell;
Mundhenke, Christoph;
Lederer, Bianca;
Solbach, Christine;
Karn, Thomas;
Marmé, Frederik;
Nekljudova, Valentina;
Schem, Christian;
Stickeler, Elmar;
Willumsen, Nicholas;
Karsdal, Morten A.;
Untch, Michael;
Müller, Volkmar

Publication type:

Article

Core-shell iron oxide-platinium@metal organic framework/epirubicin nanospheres: Synthesis, characterization and anti-breast cancer activity.

Published in:

Arabian Journal of Chemistry, 2023, v. 16, n. 11, p. N.PAG, doi. 10.1016/j.arabjc.2023.105229

By:

Li, Jiadi;
Zhou, Yuxin;
Yan, Shuixin;
Wu, Weizhu;
Sharifi, Majid

Publication type:

Article

Development and validation of an HPLC-DAD method for the simultaneous identification and quantification of Topotecan, Irinotecan, Etoposide, Doxorubicin and Epirubicin.

Published in:

Arabian Journal of Chemistry, 2021, v. 14, n. 1, p. N.PAG, doi. 10.1016/j.arabjc.2020.11.002

By:

Sanogo, Seydou;
Silimbani, Paolo;
Gaggeri, Raffaella;
Masini, Carla

Publication type:

Article

Differential immunomodulatory effects of epirubicin/cyclophosphamide and docetaxel in breast cancer patients.

Published in:

Journal of Experimental & Clinical Cancer Research (17569966), 2023, v. 42, n. 1, p. 1, doi. 10.1186/s13046-023-02876-x

By:

Wimmer, Kerstin;
Sachet, Monika;
Ramos, Cristiano;
Frantal, Sophie;
Birnleitner, Hanna;
Brostjan, Christine;
Exner, Ruth;
Filipits, Martin;
Bago-Horvath, Zsuzsanna;
Rudas, Margaretha;
Bartsch, Rupert;
Gnant, Michael;
Singer, Christian F.;
Balic, Marija;
Egle, Daniel;
Oehler, Rudolf;
Fitzal, Florian

Publication type:

Article

Successful Treatment of Therapy-related Acute Promyelocytic Leukemia with All-trans-retinoic acid Following Epirubicin for Hepatocellular Carcinoma and Docetaxel and Pembrolizumab Therapies for Lung Carcinoma: A Triple Malignancy Case.

Published in:

2020

By:

SUZUKI, Rikio;
KAWAI, Hidetsugu;
FURUYA, Daisuke;
AKASHI, Hibiki;
OGAWA, Yoshiaki;
KAWADA, Hiroshi;
ANDO, Kiyoshi

Publication type:

Case Study

Epirubicin Treatment Induces Neurobehavioral, Oxido-Inflammatory and Neurohistology Alterations in Rats: Protective Effect of the Endogenous Metabolite of Tryptophan − 3-Indolepropionic Acid.

Published in:

Neurochemical Research, 2023, v. 48, n. 9, p. 2767, doi. 10.1007/s11064-023-03941-9

By:

Owumi, Solomon E.;
Adebisi, Grace

Publication type:

Article

PREPARATION OF FOLATE-CONJUGATED BOVINE SERUM ALBUMIN NANOPARTICLES ADSORBING EPIRUBICIN HYDROCHLORIDE.

Published in:

NANO (1793-2920), 2013, v. 8, n. 6, p. 1, doi. 10.1142/S1793292013500665

By:

XIUHUA ZHAO;
JIAMING TANG;
YUANGANG ZU;
WEIGUO WANG;
NA LI;
WENJIA XU

Publication type:

Article

Conventional versus reverse sequence of neoadjuvant epirubicin/cyclophosphamide and docetaxel: sequencing results from ABCSG-34.

Published in:

2021

By:

Bartsch, Rupert;
Singer, Christian F.;
Pfeiler, Georg;
Hubalek, Michael;
Stoeger, Herbert;
Pichler, Angelika;
Petru, Edgar;
Bjelic-Radisic, Vesna;
Greil, Richard;
Rudas, Margaretha;
Muy-Kheng, Tea Maria;
Wette, Viktor;
Petzer, Andreas L.;
Sevelda, Paul;
Egle, Daniel;
Dubsky, Peter C.;
Filipits, Martin;
Fitzal, Florian;
Exner, Ruth;
Jakesz, Raimund

Publication type:

journal article

Ki-67 response-guided preoperative chemotherapy for HER2-positive breast cancer: results of a randomised Phase 2 study.

Published in:

2020

By:

Mukai, Hirofumi;
Yamaguchi, Takeshi;
Takahashi, Masato;
Hozumi, Yasuo;
Fujisawa, Tomomi;
Ohsumi, Shozo;
Akabane, Hiromitsu;
Nishimura, Reiki;
Takashima, Tsutomu;
Park, Youngjin;
Sagara, Yasuaki;
Toyama, Tatsuya;
Imoto, Shigeru;
Mizuno, Toshiro;
Yamashita, Satoshi;
Fujii, Satoshi;
Uemura, Yukari

Publication type:

journal article

Dose-dense adjuvant chemotherapy in early breast cancer patients: 15-year results of the Phase 3 Mammella InterGruppo (MIG)-1 study.

Published in:

2020

By:

Blondeaux, Eva;
Lambertini, Matteo;
Michelotti, Andrea;
Conte, Benedetta;
Benasso, Marco;
Dellepiane, Chiara;
Bighin, Claudia;
Pastorino, Simona;
Levaggi, Alessia;
Alonzo, Alessia D';
Poggio, Francesca;
Buzzatti, Giulia;
Molinelli, Chiara;
Fregatti, Piero;
Bertoglio, Sergio;
Boccardo, Francesco;
Del Mastro, Lucia

Publication type:

journal article

Immune gene expression and response to chemotherapy in advanced breast cancer.

Published in:

2018

By:

Foukakis, Theodoros;
Lövrot, John;
Matikas, Alexios;
Zerdes, Ioannis;
Lorent, Julie;
Tobin, Nick;
Suzuki, Chikako;
Brage, Suzanne Egyházi;
Carlsson, Lena;
Einbeigi, Zakaria;
Linderholm, Barbro;
Loman, Niklas;
Malmberg, Martin;
Fernö, Mårten;
Skoog, Lambert;
Bergh, Jonas;
Hatschek, Thomas;
Lövrot, John;
Brage, Suzanne Egyházi;
Fernö, Mårten

Publication type:

journal article

High-dose Tamoxifen plus Ifosfamide and Anthracycline in a Patient with Angiosarcoma of the Breast.

Published in:

2013

By:

Hsiao, C. -H.;
Yeh, K. -H.;
Chang, Y. -C.;
Tsai, C. -C.

Publication type:

Case Study

HER2 and TOP2A in high-risk early breast cancer patients treated with adjuvant epirubicin-based dose-dense sequential chemotherapy.

Published in:: Journal of Translational Medicine, 2012, v. 10, n. 1, p. 10, doi. 10.1186/1479-5876-10-10
Publication type:: Article

Effectiveness and safety of pegylated liposomal doxorubicin versus epirubicin as neoadjuvant or adjuvant chemotherapy for breast cancer: a real-world study.

Published in:

2021

By:

Zhang, Jin;
Jiang, Hongchuan;
Zhang, Jian;
Bao, Guoqiang;
Zhang, Guoqiang;
Wang, Haibo;
Wang, Xi

Publication type:

journal article